gi-hepatology
Index of Severity for Eosinophilic Oesophagitis (I-SEE)
Comprehensive index combining histological (eosinophil count) and endoscopic (EREFS) features to assess disease severity in eosinophilic oesophagitis (EoE). Validated for monitoring treatment response.
References
- Warners MJ et al. The esophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic esophagitis. Gut. 2017;66(1):59-66.
- Dellon ES et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155(4):1022-1033.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Dupilumab · Biologic (IL-4 / IL-13 receptor antagonist)
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Dupilumab (CRSwNP) · IL-4Rα Inhibitor (Anti-IL-4/IL-13)
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.